Scilex Holding Co

Scilex Holding Company (ticker: SCLX) is a healthcare-sector special purpose acquisition company that completed its initial public offering in 2021, sponsored by Vickers Capital Group through Vickers Vantage Corp. I. In December 2021, the company filed an amended Form 10-Q/A with the SEC, updating quarterly disclosures during its post-IPO target search period. The SPAC subsequently announced and completed a business combination with Scilex Pharmaceuticals, a specialty pharmaceutical company focused on non-opioid pain management therapies and formerly a subsidiary of Sorrento Therapeutics, bringing a commercial-stage drug portfolio into the public markets via the blank-check structure. For the complete filing history, deal timeline, and analytics on SCLX, sign up for full data access on SpacDesk.